BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33156495)

  • 1. Imaging Early-Stage Metastases Using an
    Mason CA; Carter LM; Mandleywala K; de Souza Franca PD; Meyer JP; Mamun T; Backer JM; Backer MV; Reiner T; Lewis JS
    Mol Imaging Biol; 2021 Jun; 23(3):340-349. PubMed ID: 33156495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants.
    Meyer JP; Edwards KJ; Kozlowski P; Backer MV; Backer JM; Lewis JS
    J Nucl Med; 2016 Nov; 57(11):1811-1816. PubMed ID: 27390161
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Gao F; Zhang Y; Chen M; Song Z; Dong R; Qiu S; Shen C; Huang X; Geng H; Cheng W; Hu J
    Eur J Pharm Sci; 2024 Feb; 193():106671. PubMed ID: 38104907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Imaging of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Atherosclerotic Lesions in Diabetic and Non-diabetic ApoE
    Tekabe Y; Johnson LL; Rodriquez K; Li Q; Backer M; Backer JM
    Mol Imaging Biol; 2018 Feb; 20(1):85-93. PubMed ID: 28421362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer.
    Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C
    Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Evaluation of [
    Huang J; Bai L; Shi D; Jiang W; Chen P; Dong Y; Zhang X; Peng J; Hou J; Lu Y; Huang X; Tang G; Huang S
    Mol Pharm; 2024 May; 21(5):2425-2434. PubMed ID: 38554143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.
    Persson M; Liu H; Madsen J; Cheng Z; Kjaer A
    Nucl Med Biol; 2013 Jul; 40(5):618-24. PubMed ID: 23602763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of renal clearance of [
    Liu J; Guo X; Wen L; Wang L; Liu F; Song G; Zhu H; Zhou N; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2775-2786. PubMed ID: 37093312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High in-vivo stability in preclinical and first-in-human experiments with [
    Qin X; Guo X; Liu T; Li L; Zhou N; Ma X; Meng X; Liu J; Zhu H; Jia B; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):302-313. PubMed ID: 36129493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
    Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
    Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro and In Vivo Characterization of an
    Lütje S; Franssen GM; Herrmann K; Boerman OC; Rijpkema M; Gotthardt M; Heskamp S
    J Nucl Med; 2019 Jul; 60(7):1017-1022. PubMed ID: 30655329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2.
    Gao H; Lang L; Guo N; Cao F; Quan Q; Hu S; Kiesewetter DO; Niu G; Chen X
    Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):683-92. PubMed ID: 22274731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new PET tracer specific for vascular endothelial growth factor receptor 2.
    Wang H; Cai W; Chen K; Li ZB; Kashefi A; He L; Chen X
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2001-10. PubMed ID: 17694307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CEA antibody fragments labeled with [(18)F]AlF for PET imaging of CEA-expressing tumors.
    Lütje S; Franssen GM; Sharkey RM; Laverman P; Rossi EA; Goldenberg DM; Oyen WJ; Boerman OC; McBride WJ
    Bioconjug Chem; 2014 Feb; 25(2):335-41. PubMed ID: 24382090
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Gao F; Peng C; Zhuang R; Guo Z; Liu H; Huang L; Li H; Xu D; Wen X; Fang J; Zhang X
    Nucl Med Biol; 2019; 72-73():62-69. PubMed ID: 31330414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence.
    Zhang Y; Hong H; Nayak TR; Valdovinos HF; Myklejord DV; Theuer CP; Barnhart TE; Cai W
    Angiogenesis; 2013 Jul; 16(3):663-74. PubMed ID: 23471463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121.
    Zhang Y; Hong H; Niu G; Valdovinos HF; Orbay H; Nayak TR; Chen X; Barnhart TE; Cai W
    Mol Pharm; 2012 Dec; 9(12):3586-94. PubMed ID: 23137334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient [(18)F]AlF Radiolabeling of ZHER3:8698 Affibody Molecule for Imaging of HER3 Positive Tumors.
    Da Pieve C; Allott L; Martins CD; Vardon A; Ciobota DM; Kramer-Marek G; Smith G
    Bioconjug Chem; 2016 Aug; 27(8):1839-49. PubMed ID: 27357023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative PET imaging of VEGF receptor expression.
    Chen K; Cai W; Li ZB; Wang H; Chen X
    Mol Imaging Biol; 2009; 11(1):15-22. PubMed ID: 18784964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation,
    Barta P; Kamaraj R; Kucharova M; Novy Z; Petrik M; Bendova K; Hajduch M; Pavek P; Trejtnar F
    Bioconjug Chem; 2022 Oct; 33(10):1825-1836. PubMed ID: 36197842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.